When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare disease hereditary ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.